RxDoctor Payments Data

Jennifer Delk

Family · Franklin, KYNPI 1205165156

Payments from drug & device makers

$4,418in general payments, 2019–2025

Across 293 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$919
  • AbbVie$762
  • Amgen$367
  • Novo Nordisk$248
  • Bayer$215
  • Lilly USA, LLC$203
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,418100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,418 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$132,651
Medicare patients
313
Services billed
5,348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide76$101,848
Trelegy ElliptaFluticasone/Umeclidin/Vilanter104$69,379
Tresiba Flextouch U-200Insulin Degludec35$53,024
EliquisApixaban66$51,727
MounjaroTirzepatide19$29,994
JardianceEmpagliflozin26$26,291
FarxigaDapagliflozin Propanediol22$23,764
MyrbetriqMirabegron32$22,701
LinzessLinaclotide25$17,904
JanuviaSitagliptin Phosphate25$15,037
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$14,765
TrulancePlecanatide16$11,548
Repatha SureclickEvolocumab15$9,747
TradjentaLinagliptin14$9,737
XareltoRivaroxaban16$8,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$248$101,84876 claims
GSKTrelegy Ellipta$141$69,379104 claims
PfizerEliquis$203$51,72766 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$169$46,39751 claims
Boehringer IngelheimJardiance, Tradjenta$58$36,02740 claims
Lilly USA, LLCMounjaro$203$29,99419 claims
Astellas Pharma US IncMyrbetriq$73$22,70132 claims
MerckJanuvia, Janumet$13$21,37937 claims
AbbVieLinzess, Synthroid$762$20,74368 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$919$11,54816 claims
Johnson & JohnsonXarelto$59$8,93716 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$15$8,08511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Franklin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →